Stepped Surgery in Uveitic Cataract: A Novel Approach to a Quiet Eye
1 other identifier
interventional
10
1 country
1
Brief Summary
This study aims to assess the short-term results of primary phacoemulsification and secondary posterior chamber intraocular lens (PCIOL) implantation in patients with uveitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 8, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2021
CompletedFirst Submitted
Initial submission to the registry
June 12, 2021
CompletedFirst Posted
Study publicly available on registry
June 18, 2021
CompletedJune 23, 2021
June 1, 2021
3 months
June 12, 2021
June 18, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Visulal acuity
overall improvement in vision using LogMAR
6 months
Secondary Outcomes (1)
Intraocular inflammation
6 months
Study Arms (1)
stepped cataract surgery
OTHERInterventions
stepped surgery in the form of primary phacoemulsification and secondary posterior chamber intraocular lens (PCIOL) implantation in patients with uveitis.
Eligibility Criteria
You may qualify if:
- the study will include any uveitic patients below 45 years old with complicated cataract and their best corrected visual acuity (BCVA) not better than 6/36 nor worse than hand movement
You may not qualify if:
- the study will not include those with visual acuity more than 6/36 or patients with active uveitis or with posterior segment pathology discovered by ultrasonography that may affect to a lager extent the visual prognosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mansoura university
Al Mansurah, Dakahlyia, 35516, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amgad El Nokrashy, MD
Mansoura University
- STUDY CHAIR
Dina Abd El Fattah, MD
Mansoura University
- STUDY CHAIR
Rania Bassiouny, MD
Mansoura University
- STUDY CHAIR
Shreen Gaafar, MD
Mansoura University
- STUDY DIRECTOR
Waleed Gaafar, MD
Mansoura University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of Ophthalmology
Study Record Dates
First Submitted
June 12, 2021
First Posted
June 18, 2021
Study Start
February 8, 2021
Primary Completion
May 15, 2021
Study Completion
May 30, 2021
Last Updated
June 23, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share
results